Seattle law firm Hagens Berman Sobol Shapiro said it has filed a shareholder lawsuit against CellCyte Genetics, accusing the biotech company and its officers of artificially inflating its stock price ...
In case you were wondering why counsel always cuts the hype out of your press releases--CellCyte Genetics and its former top execs got slapped with an SEC lawsuit for their role in a hype-driven ...
The SEC has filed a lawsuit against Bothell, WA-based CellCyte Genetics and two former executives for lying to investors regarding its stem cell therapies. The developer has already been in hot water ...
The goal of the study is to investigate the efficiency of CellCyte's glycoprotein products in a preclinical model of myocardial infarction (heart attack). "We look forward to working with the ...
Seattle law firm Hagens Berman Sobol Shapiro said it has filed a shareholder lawsuit against CellCyte Genetics, accusing the biotech company and its officers of artificially inflating its stock price ...
SEATTLE (CN) - CellCyte Genetics defrauded the public by claiming that its stem-cell technology had been proven successful and was headed for human trials, the SEC claims in Federal Court. The bogus ...
The beleaguered Securities & Exchange Commission has brought civil fraud charges against CellCyte Genetics and two ex-executives, nearly two years after Forbes became the first in the media to point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results